Filing Details

Accession Number:
0001267602-19-000187
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2019-11-19 16:18:16
Reporting Period:
2019-11-14
Accepted Time:
2019-11-19 16:18:16
Original Submission Date:
2019-11-14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267602 Alimera Sciences Inc ALIM Pharmaceutical Preparations (2834) 200028718
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1374256 Jr S Richard Eiswirth 6120 Windward Parkway, Suite 290
Alpharetta GA 30005
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-14 75,000 $0.30 438,901 No 4 P Direct
Common Stock Acquisiton 2019-11-14 25,000 $0.30 463,901 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents shares of common stock that were acquired by the reporting person on the open market. Actual purchase prices ranged from $0.2910 to $0.3030.
  2. Reporting person's original Form 4 mistakenly reported Transaction Code "A".
  3. On November 14, 2019, after the close of business, the issuer effected a one-for-15 reverse stock split. The amounts shown in Table I above reflect the amounts reported on the original Form 4. As of the date that this Form 4/A is filed, taking the reverse stock split into account, the amount shown in column 5 would be 30,926 shares.
  4. Ownership is in the name of RICHARD S EISWIRTH, JR IRA SEP.